TVRD Latest Press Releases

-- January 8, 2026 --

Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 4:05 PM

Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights Globe Newswire 8:00 AM

-- December 24, 2025 --

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics Globe Newswire 11:23 AM

-- December 23, 2025 --

INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PRNewswire 10:18 AM

-- December 21, 2025 --

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics Business Wire 10:11 AM

-- December 20, 2025 --

SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics Globe Newswire 8:01 AM

-- December 17, 2025 --

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PRNewswire 10:31 AM

-- December 11, 2025 --

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PRNewswire 10:15 AM

-- December 4, 2025 --

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PRNewswire 10:28 AM

-- December 3, 2025 --

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics Globe Newswire 9:50 AM

-- November 30, 2025 --

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PRNewswire 9:46 AM

-- November 29, 2025 --

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics Globe Newswire 8:51 AM

-- November 21, 2025 --

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PRNewswire 10:08 AM

-- November 20, 2025 --

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics Globe Newswire 2:36 PM

-- November 18, 2025 --

Tvardi Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference Business Wire 8:00 AM

-- November 14, 2025 --

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi PRNewswire 10:31 AM

-- November 13, 2025 --

Tvardi Therapeutics Announces Third Quarter 2025 Results and Provides Business Update Business Wire 4:01 PM

-- November 9, 2025 --

TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics Globe Newswire 9:18 AM

-- November 6, 2025 --

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi Business Wire 11:07 AM

-- November 5, 2025 --

TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Globe Newswire 10:40 AM

-- November 4, 2025 --

Tvardi Therapeutics to Participate in the Jefferies Global Healthcare Conference in London Business Wire 8:00 AM

-- November 3, 2025 --

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PRNewswire 10:19 AM

-- October 31, 2025 --

TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Business Wire 9:50 PM

-- October 28, 2025 --

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PRNewswire 9:31 AM

-- October 26, 2025 --

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics Globe Newswire 9:18 AM

-- October 24, 2025 --

Rosen Law Firm Encourages Tvardi Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - TVRD Business Wire 6:00 PM

-- October 23, 2025 --

Faruqi & Faruqi Reminds Tvardi Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 3, 2025 - TVRD PRNewswire 1:05 PM

-- October 15, 2025 --

TVRD SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics PRNewswire 10:02 AM

-- October 13, 2025 --

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics Business Wire 6:27 PM

Tvardi Therapeutics Provides Update on Preliminary Data from Phase 2 REVERT Trial in Idiopathic Pulmonary Fibrosis Business Wire 7:30 AM